Medical Services International Inc. Continues to Add Distributors to Its Distribution Network

EDMONTON, Alberta, Oct. 30 Medical ServicesInternational Inc. (OTC Pink Sheets: MSITF) is pleased to announce that it hasadded 4 additional distributors in the month of October, 2007. In order tomaintain their distributorships these corporations will have to purchase atotal of 750,000 test kits in the next year. The primary focus of thesedistributors is Dengue Fever and Malaria. There is a significant demand for aDengue Fever Kit and only one other manufacturer currently in the world. TheCompany continues to negotiate with another 6 companies to become distributorsprimarily for the VScan TB test. Tuberculosis (TB) continues to spread at analarming rate particularly in Eastern Europe.

Medical Services International Inc. trades in the United States on the NQBPink Sheets under the symbol "MSITF". For further information, please contactRobert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com orhttp://www.minerva-biotech.com.

NOTE: Certain statements in this press release are "forward-lookingstatements" within the meaning of the Private Securities Act of 1995. Suchstatements involve known and unknown risks, uncertainties and other factorsthat may cause results to differ materially. Such risks, uncertainties andother factors include but are not limited to new economic conditions, risk inproduct development, market acceptance of new products and continuing productdemand, level of competition and other factors described in Company reportsand other filings with regulatory bodies.

SOURCE Medical Services International Inc.

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...